X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (151) 151
oncology (109) 109
female (88) 88
male (85) 85
middle aged (66) 66
index medicus (65) 65
adult (63) 63
aged (62) 62
pharmacokinetics (51) 51
neoplasms - drug therapy (48) 48
article (46) 46
animals (41) 41
cancer (40) 40
dose-response relationship, drug (33) 33
antineoplastic agents - pharmacokinetics (32) 32
mice (31) 31
pharmacology & pharmacy (28) 28
antineoplastic agents - administration & dosage (26) 26
treatment outcome (25) 25
area under curve (24) 24
neoplasms - metabolism (24) 24
research (23) 23
drug administration schedule (22) 22
aged, 80 and over (21) 21
antineoplastic agents - adverse effects (20) 20
chemotherapy (19) 19
phase-i (19) 19
antineoplastic combined chemotherapy protocols - therapeutic use (18) 18
child (18) 18
sorafenib (18) 18
antineoplastic agents - therapeutic use (17) 17
chemistry, analytical (17) 17
docetaxel (17) 17
metabolism (17) 17
niacinamide - analogs & derivatives (17) 17
adolescent (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
cell line, tumor (15) 15
cells (15) 15
infusions, intravenous (15) 15
taxoids - pharmacokinetics (15) 15
antineoplastic agents, phytogenic - pharmacokinetics (14) 14
biochemical research methods (14) 14
leukemia, myeloid, acute - drug therapy (14) 14
mass spectrometry (14) 14
metabolic clearance rate (14) 14
reproducibility of results (14) 14
time factors (14) 14
acute myeloid leukemia (13) 13
acute myeloid-leukemia (13) 13
administration, oral (13) 13
analysis (13) 13
antineoplastic combined chemotherapy protocols - pharmacokinetics (13) 13
leukemia (13) 13
mutation (13) 13
calibration (12) 12
child, preschool (12) 12
protein kinase inhibitors - pharmacokinetics (12) 12
sensitivity and specificity (12) 12
clinical pharmacokinetics (11) 11
expression (11) 11
genetic aspects (11) 11
pharmacology (11) 11
antineoplastic agents - pharmacology (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
care and treatment (10) 10
cytarabine (10) 10
cytosine - analogs & derivatives (10) 10
drug interactions (10) 10
genetics & heredity (10) 10
in-vitro (10) 10
lc/ms/ms (10) 10
medicine & public health (10) 10
paclitaxel (10) 10
paclitaxel - pharmacokinetics (10) 10
pharmacology/toxicology (10) 10
taxoids - administration & dosage (10) 10
camptothecin - analogs & derivatives (9) 9
chromatography, high pressure liquid (9) 9
dosage and administration (9) 9
hematology (9) 9
maximum tolerated dose (9) 9
medical research (9) 9
mice, knockout (9) 9
neoplasms - pathology (9) 9
neutropenia - chemically induced (9) 9
tissue distribution (9) 9
trial (9) 9
abridged index medicus (8) 8
acute myelogenous leukemia (8) 8
antimetabolites, antineoplastic - pharmacokinetics (8) 8
antineoplastic agents (8) 8
antineoplastic agents, phytogenic - therapeutic use (8) 8
apoptosis (8) 8
carcinoma (8) 8
cytochrome p-450 cyp3a (8) 8
genetics (8) 8
genotype (8) 8
human plasma (8) 8
imatinib mesylate (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical pharmacology and therapeutics, ISSN 0009-9236, 07/2019
Systemic therapy of advanced hepatocellular carcinoma (HCC) with the small-molecule multikinase inhibitor sorafenib is associated with large interindividual... 
Index Medicus | Abridged Index Medicus
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 08/2019, p. clincanres.0470.2019
To determine the pharmacokinetics and skin toxicity profile of sorafenib in children with refractory/relapsed malignancies. Sorafenib was administered... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 1882 - 1882
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 257 - 257
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4786 - 4786
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3937 - 3937
Abstract Background: Crenolanib is a novel type I pan-FLT3 inhibitor, which inhibits both FLT3-ITD, as well as FLT3 tyrosine kinase domain (TKD) activating... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3695 - 3695
Abstract Background: Crenolanib besylate is a selective and potent type I tyrosine kinase inhibitor (TKI) of wild-type and mutant FMS-like tyrosine kinase 3... 
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 3696 - 3696
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 5464 - 5464
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2838 - 2838
Abstract Pediatric cancers are distinct from adult cancers in both their genomic alterations and therapeutic responses. Fms-like tyrosine kinase 3 (FLT3)... 
Journal Article
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, ISSN 1570-0232, 05/2016, Volume 1020, p. 167
Journal Article
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 05/2016, Volume 1020, p. 167
(b) Division of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA 
Mass spectrometry | High performance liquid chromatography
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3620 - 3620
Abstract A common mechanism associated with clinical resistance to FLT3 inhibitors (e.g., sorafenib and quizartinib) in FLT3-ITD+ AML is the acquisition of... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2011, Volume 29, Issue 15, pp. e456 - e457
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.